Panacea Biotec has maintained highest standard of quality at all times. With a zeal to offer the best products for ailing humanity, the Research team has developed novel drug delivery systems to increase effectiveness, tolerability and compliance.  Nimulid Transgel, Safeinject, Willgo, Xeed are just a few technological innovations.  In the domestic market Panacea Biotec has an established brand equity in branded pharmaceutical formulations including pain management, cardiovascular disorders, diabetes management and organ transplant. Its leading brands are amongst the top 5 positions in their respective therapeutic segments. Its promising brands are amongst the top 200 brands in India with Glizid-M ranking at 133 and Nimulid as a brand at 177 according to the secondary stockiest audit by ORG IMS (MAT March, 2007).